Cerevel Therapeutics Hldg Stock (NASDAQ: CERE) stock price, news, charts, stock research, profile.
Open | $44.42 |
Close | $44.62 |
Volume / Avg. | 2.05M / 1.73M |
Day Range | 44.38 - 44.66 |
52 Wk Range | 19.59 - 44.54 |
Market Cap | $8.13B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 72 |
Short Interest | 6.88% |
Days to Cover | 3.34 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cerevel Therapeutics Hldg (NASDAQ:CERE) through any online brokerage.
Other companies in Cerevel Therapeutics Hldg’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Ionis Pharmaceuticals (NASDAQ:IONS).
There is no analysis for Cerevel Therapeutics Hldg.
Cerevel Therapeutics Hldg has a consensus price target of $40.67.
The stock price for Cerevel Therapeutics Hldg (NASDAQ: CERE) is $44.6 last updated July 26, 2024 at 4:31 PM EDT.
There are no upcoming dividends for Cerevel Therapeutics Hldg.
Cerevel Therapeutics Hldg’s Q1 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for Cerevel Therapeutics Hldg.
Cerevel Therapeutics Hldg is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.